Words and photographs by Rolanda Gott, M.D.Clinical Medical Director, UCLA Developmental-Behavioral Pediatrics
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects approximately 1 in 36 children in the United States. Challenges in social interaction, communication, and repetitive behaviors characterize it. While autism presents differently in everyone, growing awareness and improved screening have led to earlier and more accurate diagnosis across a broader spectrum, including children with advanced cognitive skills or subtle social communication difficulties.
The increase in autism diagnosis over the past decade can be attributed to several factors: broader diagnostic criteria, a better understanding of early signs, and improved access to evaluations. New genetic syndromes associated with ASD are also being identified, prompting more referrals for assessment. Despite these advances, the exact causes of autism remain only partially understood. Research points to a complex interplay of genetic predisposition and environmental risk factors, such as advanced parental age, prenatal exposures, prematurity, and perinatal complications.
Importantly, studies confirm that autism develops in utero, with changes in brain structure occurring during early fetal development. Around 25% of children with ASD experience regression in language or social interaction between the ages of 1 and 2. This timing often coincides with routine childhood vaccinations, leading to persistent but unfounded concerns about a link to the MMR (Measles, Mumps, Rubella) vaccine. Based on extensive research, there is no scientific evidence supporting a connection between vaccines and autism, and the American Academy of Pediatrics (AAP) strongly recommends routine immunization for all children.
Why Early Intervention Matters?
Autism is best understood as a learning and developmental disorder. Early intervention, especially speech, social engagement, and behavior therapies, can significantly improve a child’s communication and adaptive functioning. The AAP recommends universal autism screening for all children between 18 and 30 months and monitoring for early red flags, such as reduced eye contact, lack of social smiles, or failure to respond to names.

Although a clinical diagnosis can be made as early as age 1, limited resources mean that the average age of diagnosis in the U.S. is still around 51 months. Boys are diagnosed four times more frequently than girls, partly because girls may better mask their symptoms. While awaiting formal services, families are encouraged to support their child’s development through interactive play, reading, talking, and limiting screen time. Pediatricians should guide families to early intervention or school-based programs, including audiology testing and therapy.
Reframing the Diagnosis
A diagnosis of autism should be presented not as a disability but as a difference in development, and as a key that unlocks access to services. Most children with ASD do not have intellectual disabilities, but many face challenges with independence and are at higher risk for conditions such as ADHD and anxiety. Clinicians and educators are encouraged to emphasize each child’s strengths and potential for progress.
Navigating available services can be complex. Coordinated care through a medical home, parent mentorship, family navigators, and case management (e.g., via Regional Centers) can be invaluable. Children under age 3 are eligible for early intervention programs, while those aged 3–21 can receive services through their local school district. Inclusion in mainstream educational settings and individualized support, such as one-to-one aides, promote social development and academic success.
Behavioral therapies like Applied Behavior Analysis (ABA) are most effective in younger children, while Cognitive Behavioral Therapy (CBT) is recommended for older children with anxiety. Social skills and daily living skills should be an ongoing focus of intervention. Starting at age 14, schools must develop transition plans for post-secondary education or vocational training.
Medical and Supportive Care
Genetic testing is recommended for all children diagnosed with autism to identify possible underlying conditions. For children experiencing regression without progress in therapy, additional evaluations, such as a 23-hour EEG, can help detect seizure disorders. Addressing co-occurring medical issues such as sleep disturbances, gastrointestinal problems, nutritional deficiencies, and anxiety is crucial to improving quality of life.

While there is currently no cure for autism, treating comorbid conditions and providing tailored support can significantly enhance outcomes. Medications may be prescribed to manage symptoms of ADHD, anxiety, sleep disturbances, or seizures. Although alternative therapies and special diets are popular among families, there is limited evidence supporting their effectiveness in treating autism symptoms. Ongoing research is exploring promising areas such as the gut-brain connection, cannabis-based treatments, leucovorin supplementation, and biofeedback. Children who develop functional language by age six, demonstrate adaptive skills, and have strong family support tend to achieve the best long-term outcomes.
Building a More Inclusive Society
Participation in inclusive programs, such as Unified Sports through Special Olympics or adaptive physical education, helps reduce stigma, improve peer relationships, and enhance future employability for individuals with autism. As children grow into adulthood, the focus should shift to job readiness, life skills, and supported independence.
Understanding autism requires moving beyond stereotypes and embracing the diverse abilities of individuals on the spectrum. We can empower every child to reach their full potential through early diagnosis, appropriate intervention, and inclusive practices.
About the author
Rolanda Gott, MD, FAAP – Professor of Pediatrics, Department of Pediatrics, UCLA School of Medicine, Alisson Shapiro Term Chair for Children’s Cognitive Development, Clinical Medical Director, UCLA Developmental and Behavioral Pediatrics (DBP) Board of Directors &Health Committee, Southern California Special Olympics (SOSC).
Dr. Gott is the medical director of UCLA DBP and an expert in the diagnosis, teaching, advocacy, and research in the field of Autism (ASD) and Developmental Disabilities (DD). As part of the SOSC Board of Directors, Dr. Gott has advocated for unified health care. Through international lectures and media, Dr. Gott has advocated for a global evaluation approach for ASD and initiated the introduction of the BOSA autism diagnostic tool in Romania. Dr. Gott received multiple awards for her clinical, advocacy, and academic accomplishments.

